Research ArticleOriginal Article
Open Access
Tolerability of propofol in Wada testing
Faisal A. Alsallom, Shobhit Sinha, Fahmi M. Alsenani, Fawziah A. Bamogaddam, Saeed H. Wahass, Aurora B. Canillo and Khurram A. Siddiqui
Neurosciences Journal July 2014, 19 (3) 218-223;
Faisal A. Alsallom
From the Departments of Neurology (Alsallom, Alsenani, Bamogaddam, Canillo), Neuroradiology (Alsenani), and Neuropsychology (Wahass), National Neurosciences Institute, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Sinha) Division of Neurology, Al-Mafraq Hospital, Abu Dhabi, and the Department of Neurology (Siddiqui), Medical Institute, Al-Ain Hospital, Al-Ain, United Arab Emirates
MBBSShobhit Sinha
From the Departments of Neurology (Alsallom, Alsenani, Bamogaddam, Canillo), Neuroradiology (Alsenani), and Neuropsychology (Wahass), National Neurosciences Institute, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Sinha) Division of Neurology, Al-Mafraq Hospital, Abu Dhabi, and the Department of Neurology (Siddiqui), Medical Institute, Al-Ain Hospital, Al-Ain, United Arab Emirates
MBBS,FRCPFahmi M. Alsenani
From the Departments of Neurology (Alsallom, Alsenani, Bamogaddam, Canillo), Neuroradiology (Alsenani), and Neuropsychology (Wahass), National Neurosciences Institute, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Sinha) Division of Neurology, Al-Mafraq Hospital, Abu Dhabi, and the Department of Neurology (Siddiqui), Medical Institute, Al-Ain Hospital, Al-Ain, United Arab Emirates
MBBS,MScFawziah A. Bamogaddam
From the Departments of Neurology (Alsallom, Alsenani, Bamogaddam, Canillo), Neuroradiology (Alsenani), and Neuropsychology (Wahass), National Neurosciences Institute, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Sinha) Division of Neurology, Al-Mafraq Hospital, Abu Dhabi, and the Department of Neurology (Siddiqui), Medical Institute, Al-Ain Hospital, Al-Ain, United Arab Emirates
MDSaeed H. Wahass
From the Departments of Neurology (Alsallom, Alsenani, Bamogaddam, Canillo), Neuroradiology (Alsenani), and Neuropsychology (Wahass), National Neurosciences Institute, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Sinha) Division of Neurology, Al-Mafraq Hospital, Abu Dhabi, and the Department of Neurology (Siddiqui), Medical Institute, Al-Ain Hospital, Al-Ain, United Arab Emirates
PhDAurora B. Canillo
From the Departments of Neurology (Alsallom, Alsenani, Bamogaddam, Canillo), Neuroradiology (Alsenani), and Neuropsychology (Wahass), National Neurosciences Institute, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Sinha) Division of Neurology, Al-Mafraq Hospital, Abu Dhabi, and the Department of Neurology (Siddiqui), Medical Institute, Al-Ain Hospital, Al-Ain, United Arab Emirates
BSKhurram A. Siddiqui
From the Departments of Neurology (Alsallom, Alsenani, Bamogaddam, Canillo), Neuroradiology (Alsenani), and Neuropsychology (Wahass), National Neurosciences Institute, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Sinha) Division of Neurology, Al-Mafraq Hospital, Abu Dhabi, and the Department of Neurology (Siddiqui), Medical Institute, Al-Ain Hospital, Al-Ain, United Arab Emirates
MBBS,FRCP
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Tolerability of propofol in Wada testing
Faisal A. Alsallom, Shobhit Sinha, Fahmi M. Alsenani, Fawziah A. Bamogaddam, Saeed H. Wahass, Aurora B. Canillo, Khurram A. Siddiqui
Neurosciences Journal Jul 2014, 19 (3) 218-223;
Jump to section
Related Articles
Cited By...
- No citing articles found.